Based on the company's latest reports for June 2026, the current 12-month EPS is $19.9. Chemed's earnings per share in 2025 was reported at $18.42, marking a decrease from $20.1 in 2024. In the quarterly report ending on Jun 30, 2026, CHE's earnings per share amounted to $5.14.
Chemed had an yealy earnings per share of $18.42, showing a decrease of 8.4% from $20.1 recorded in 2024. The quarterly earnings per share for the period ending Jun 30, 2026, was $5.14, showing a 42.8% increase compared to the same quarter last year. The trailing twelve months EPS for CHE is $19.9 as of June 2026. Chemed's full-year EPS for 2024 was $20.1, a 11% rise compared to the previous year.
Over the past 12 months, Chemed has recorded an earnings per share growth rate of 42.8% (YoY, quarterly). Across the past three years, the company had an average EPS annual growth rate of 3.3% per year. In the last five years, the company had an average annual EPS growth of -1.7%. When assessed over a ten-year period, CHE's average EPS annual growth was 10.9%.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| RPM RPM International Inc | 21.93 | -3.5% | 11.5% | 5.9% |
| CHE Chemed Corp | 26.78 | -8.4% | 3.3% | -1.7% |
| BCPC Balchem Corp | 34.73 | 20.9% | 13.4% | 12.8% |
| SXT Sensient Technologies Corp | 35.88 | 7.4% | -1.8% | 4.2% |
All data is based on quarterly TTM periods, unless otherwise specified.